Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT
Calidi Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 5.28M | 10.56M | 9.59M | 1.9M | 836K | 1.24M | 2.05M | 10.25M | 669.87K | 82.83K | 93.89K | 39.94K | 328.84K | 597.52K | 1.06M | 1.2M | 95K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 102K | 123K | 129K | 129K | 356K | 175K | 230K | 1.41M | 43.21M | 42.91M | 42.45M | 41.68M | 230.18M | 230.02M | 230M | 230M | n/a |
Other Long-Term Assets | 867K | 21K | 23K | 88K | -129K | 331K | 143K | 30K | -5.73M | -6.01M | -1.09M | -1.01M | 77.03K | 178.99K | 280.94K | n/a | 507.38K |
Receivables | 50K | 50K | n/a | n/a | 181K | n/a | 1.36M | n/a | 870.00 | 870.00 | 870.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 720K | 282K | 249K | 216K | 206K | 244K | 125K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 6.05M | 11.49M | 10.23M | 2.22M | 1.63M | 1.94M | 4.3M | 11.69M | 795.48K | 268.86K | 401.67K | 479.09K | 759.67K | 1.03M | 1.48M | 2M | 117.5K |
Property-Plant & Equipment | 2.33M | 3.43M | 3.8M | 4.22M | 4.58M | 4.96M | 5.34M | 5.46M | 5.73M | 6.01M | 1.09M | 1.01M | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.3M | 3.58M | 3.96M | 4.44M | 4.81M | 5.47M | 5.72M | 6.9M | 43.21M | 42.91M | 42.45M | 41.68M | 230.26M | 230.2M | 230.29M | 230M | 507.38K |
Total Assets | 9.35M | 15.06M | 14.18M | 6.66M | 6.43M | 7.41M | 10.02M | 18.59M | 44.01M | 43.18M | 42.85M | 42.16M | 231.02M | 231.24M | 231.77M | 232.01M | 624.88K |
Account Payables | 1.23M | 1.2M | 2.07M | 3.57M | 4.55M | 3.9M | 2.88M | 1.49M | 677K | 2.54M | 2.27M | 2.26M | n/a | n/a | 624K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | 2.46M | n/a | n/a | n/a | -677K | -2.54M | n/a | -2.26M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.19M | 1.13M | 3.18M | 3.09M | 2.98M | 4.24M | 807K | 3.35M | 1.49M | 1.46M | 5.42M | 4.05M | n/a | n/a | 5M | n/a | 188.8K |
Other Current Liabilities | 658K | 762K | 1.63M | 2M | -188K | 100K | n/a | 200K | -1.71M | -4.27M | -8.62M | -10.17M | 373.66K | 386.83K | -8.86M | 47.9K | 52.8K |
Total Current Liabilities | 5.35M | 5.43M | 9.5M | 11.58M | 13.05M | 14.95M | 10.23M | 10.87M | 8.18M | 6.62M | 4.54M | 1.34M | 373.66K | 386.83K | 410.99K | 47.9K | 683.18K |
Long-Term Debt | 1.22M | 600K | 600K | 2.37M | 1.93M | 3.38M | 2.06M | 1.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 103K | 87K | 128K | 176K | 565K | 697K | 2.71M | 3.46M | 926.6K | -2.39M | 624.23K | 8.82M | 9.71M | 14.07M | 16M | 20.93M | n/a |
Total Long-Term Liabilities | 1.92M | 2.34M | 2.72M | 4.88M | 5.13M | 7.03M | 8.02M | 8.81M | 4.58M | 1.54M | 1.07M | 9.03M | 9.71M | 14.07M | 16.04M | 20.93M | n/a |
Total Liabilities | 7.28M | 7.76M | 12.21M | 16.45M | 18.18M | 21.98M | 18.25M | 19.68M | 12.77M | 8.15M | 5.61M | 10.37M | 10.08M | 14.45M | 16.45M | 20.98M | 683.18K |
Total Debt | 3.41M | 4.71M | 7.04M | 9.02M | 8.73M | 11.71M | 7.24M | 9.75M | 1.49M | 1.46M | 1.22M | 460K | n/a | n/a | n/a | n/a | 188.8K |
Common Stock | n/a | 3K | 2K | 1K | 1K | 4K | 4K | 4K | 43.21M | 42.91M | 42.45M | 41.68M | 230.18M | 230.02M | 230.01M | 230M | 575.00 |
Retained Earnings | -132.42M | -126.7M | -121.72M | -117.62M | -112.56M | -106.8M | -99.57M | -91.34M | -12.15M | -7.88M | -5.21M | -9.9M | -9.24M | -13.24M | -14.69M | -18.98M | -83.3K |
Comprehensive Income | -13K | -26K | -28K | -74K | -27K | 11K | -47K | -4K | -17K | -12K | -14K | -31K | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 1.76M | 6.94M | 1.53M | -10.28M | -11.75M | -14.57M | -8.23M | -1.09M | 31.24M | 35.02M | 37.25M | 31.78M | 220.94M | 216.78M | 215.32M | 211.02M | -58.3K |
Total Investments | 102K | 123K | 129K | 129K | 356K | 175K | 230K | 1.41M | 43.21M | 42.91M | 42.45M | 41.68M | 230.18M | 230.02M | 230M | 230M | n/a |